Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

Testosterone and its byproducts help support male sexual behavior through different pathways in the brain and body.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Androgens are essential for maintaining adult neuromuscular structure.

Treatment balancing hormones stopped hair loss in most women with androgenetic alopecia.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

DHT is crucial for urethral formation, and its disruption can affect masculinization and lead to hypospadias.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Young coconut juice speeds up wound healing.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Oral contraceptives may cause hair loss in women.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Hormones and genes affect hair growth and male baldness.

Finasteride caused enlarged breast tissue in a 62-year-old man.

Androgens increase pigmentation in young hamsters, but estrogens can reverse this effect.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Early diagnosis and personalized treatment for PCOS are crucial, especially for young women in West Bengal, India.